Literature DB >> 7872393

Long-term observation of retinal lesions in tuberous sclerosis.

I E Zimmer-Galler1, D M Robertson.   

Abstract

PURPOSE: To obtain long-term photographic follow-up of retinal astrocytic hamartomas in patients with tuberous sclerosis to learn about their stability or possible growth patterns.
METHODS: Sixteen patients with a confirmed diagnosis of tuberous sclerosis and in whom retinal astrocytic hamartomas were photographed before 1986 at the Mayo Clinic underwent a complete ophthalmic examination, and fundus photographs were taken. The new photographs were compared with previous photographs, and changes in size, character, or number of retinal hamartomas were determined. The minimum follow-up period was five years.
RESULTS: A total of 37 astrocytic hamartomas were found. Follow-up ranged from almost six years to more than 34 years, with an average of 16 years. Hamartomas in three patients showed progressive or new calcification. In a fourth patient a retinal hamartoma appeared to originate from a site that had been previously photographically documented to be normal. The remaining hamartomas appeared unchanged over the follow-up period.
CONCLUSIONS: Although most retinal lesions in tuberous sclerosis remain stable, some become calcified over time. Additionally, new lesions may develop from previously normal-appearing retina.

Entities:  

Mesh:

Year:  1995        PMID: 7872393     DOI: 10.1016/s0002-9394(14)71174-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Exudative retinal astrocytic hamartoma diagnosed and treated with pars plana vitrectomy and intravitreal bevacizumab.

Authors:  M Nakayama; H Keino; A Hirakata; A A Okada; Y Terado
Journal:  Eye (Lond)       Date:  2012-06-22       Impact factor: 3.775

Review 2.  Congenital focal abnormalities of the retina and retinal pigment epithelium.

Authors:  Yingna Liu; Anthony T Moore
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

3.  Calcification of combined hamartoma of the retina and retinal pigment epithelium over 15 years.

Authors:  Colleen M Cebulla; Harry W Flynn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-23       Impact factor: 3.117

4.  Ophthalmic manifestations of tuberous sclerosis: a population based study.

Authors:  S A Rowley; F J O'Callaghan; J P Osborne
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

5.  Case report: tuberous sclerosis and persistent hyperplastic primary vitreous.

Authors:  Hayley Wong; Sarah Bowie; Shona Handisides; Julia Escardó-Paton
Journal:  BMC Ophthalmol       Date:  2022-07-16       Impact factor: 2.086

6.  Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC).

Authors:  Ofri Vorobichik Berar; Michal Tzadok; Ofira Zloto; Iris Moroz; Idan Hecht; Anne Ampaire Musika; Omer Shlomovitz; Ido-Didi Fabian; Vicktoria Vishnevskia Dai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-01       Impact factor: 3.535

7.  Aggressive retinal astrocytomas in four patients with tuberous sclerosis complex.

Authors:  Jerry A Shields; Ralph C Eagle; Carol L Shields; Brian P Marr
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Glial tumors of the retina. The 2009 King Khaled Memorial Lecture.

Authors:  Jerry A Shields; Carol L Shields
Journal:  Saudi J Ophthalmol       Date:  2009-10-24

9.  Comparison of Color Fundus Photography, Infrared Fundus Photography, and Optical Coherence Tomography in Detecting Retinal Hamartoma in Patients with Tuberous Sclerosis Complex.

Authors:  Da-Yong Bai; Xu Wang; Jun-Yang Zhao; Li Li; Jun Gao; Ning-Li Wang
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

10.  Genetics and molecular biology of tuberous sclerosis complex.

Authors:  Valerio Napolioni; Paolo Curatolo
Journal:  Curr Genomics       Date:  2008-11       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.